Aspen will spend a record sum on transforming its Port Elizabeth manufacturing site, marking the ‘single biggest pharmaceutical investment’ in South Africa to date.
The Aspen Group, a generic pharmaceutical company, is moving further into the manufacturing business with the purchase of Merck’s API manufacturing sites in the Netherlands and Iowa.
South Africa-based Aspen Pharma is to sell its Brazilian oral solid dosage form manufacturing facility to Strides Arcolab after posting a 15 per cent drop in revenues from Latin America.
GlaxoSmithKline (GSK) has sold four of its off-patent drug products
to a South African drugmaker for £170m ($336m), describing the move
as part of an ongoing effort to simplify its manufacturing
operations.
Aspen Pharmacare, Africa's largest pharmaceutical manufacturer, has
been told that it can retain a recently purchased manufacturing
facility for off-patent active pharmaceutical ingredients (APIs),
providing it continues to supply...
